SECTION 1: CLINICAL SECTION 2: DIAGNOSIS SECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENT SECTION 4: NOACs IN CLOT TREATMENT SECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASE SECTION 6: THROMBOSIS AND HYPERTENSION SECTION 7: THROMBOSIS AND HEART FAILURE SECTION 8: THROMBOSIS AND DYSLIPIDEMIA SECTON 9: THROMBOSIS AND DIABETES MELLITUS SECTION 10: THROMBOSIS AND ARRHYTHMIA SECTION 11: THROMBOSIS AND CARDIOMYOPATHY SECTION 12: THROMBOSIS AND RHD SECTION 13: DVT SECTION 14: THROMBOSIS AND PAD SECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASE SECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASE SECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASE SECTION 18: THROMBOSIS AND KIDNEY SECTION 19: THROMBOSIS AND CARDIAC SURGERY SECTION 20: THROMBOSIS AND CRITICAL CARE SECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARE SECTION 22: THROMBOSIS AND SEPSIS SECTION 23: THROMBOSIS AND WOMEN SECTION 24: THROMBOSIS AND EYE SECTION 25: THROMBOSIS AND LUNG SECTION 26: NOAC AND DRUGS INTERACTION SECTION 27: COVID-INFLICTED COAGULOPATHY SECTION 28: CLOT IN ECMO SECTION 29: THROMBOSIS AND COVID VACCINATION SECTION 30: THROMBOSIS AND NUTRITION SECTION 31: CARDIO-ONCOLOGY AND THROMBOSIS SECTION 32: POSTMITRAL CLIP THROMBOSIS SECTION 33: PEDIATRICS AND THROMBOSIS SECTION 34: SKIN AND THROMBOSIS SECTION 35: THROMBOSIS AND AVN SECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE.